"KGK Science is a global research organization specializing in natural health product research, product development and regulatory advice for both large and small companies, individual researchers and government."

During the past decade, KGK Synergize Inc. conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 3 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 2 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KGK Synergize Inc." #1 sponsor was "KGK Science Inc." with 20 trials, followed by "BIO-CAT Microbials, LLC" with 2 trials sponsored, "Cargill" with 2 trials sponsored, "Chenland Nutritionals Inc." with 2 trials sponsored and "Circassia Limited" with 2 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KGK Synergize Inc." #1 collaborator was "KGK Science Inc." with 37 trials as a collaborator, "Adiga Life Sciences, Inc." with 2 trials as a collaborator, "ChromaDex, Inc." with 2 trials as a collaborator, "Lallemand Health Solutions" with 2 trials as a collaborator and "Moyad, Mark MD MPH" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "KGK Synergize Inc." are "Healthy" (17 trials), "Hypercholesterolemia" (3 trials), "Bioavailability" (2 trials), "Body Weight" (2 trials) and "Functional Constipation" (2 trials). Many other conditions were trialed in "KGK Synergize Inc." in a lesser frequency.

Most popular intervention types in "KGK Synergize Inc." are "Dietary Supplement" (59 trials), "Other" (37 trials), "Drug" (5 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Comparator" (2 trials), "A-F Betafood" (1 trials), "ATB-346 low dose" (1 trials) and "ATB-346 mid-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "KGK Synergize Inc." are 65 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "KGK Synergize Inc.". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in KGK Synergize Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in KGK Synergize Inc., 20 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 26 trials that are defined as “Not Applicable".